BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Feline Acquired Immunodeficiency Syndrome

Below is an extended Feline Acquired Immunodeficiency Syndrome research listing. Click here to return to the Feline Acquired Immunodeficiency Syndrome main in depth entry.

Recent Publications on Feline Acquired Immunodeficiency Syndrome:

Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
BACKGROUND: Serodiagnosis of feline immunodeficiency virus (FIV) is...
Direct Link
23rd September, 2008
Department of Small Animal Clinical Sciences, College of Veterinary
Alloimmunity does not protect from challenge with the feline immunodeficiency virus.
Immune responses against polymorphic host molecules incorporated into...
Direct Link
20th September, 2008
Department of Pathobiology, University of Guelph, Guelph, ON N1G 2W1,
Recombination in feline immunodeficiency virus from feral and companion domestic cats.
BACKGROUND: Recombination is a relatively common phenomenon in...
Direct Link
4th September, 2008
Bioinformatics Institute, Allan Wilson Centre for Molecular Ecology and
Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat.
Feline immunodeficiency virus (FIV) causes progressive immunodeficiency in...
Direct Link
3rd September, 2008
Department of Molecular Biology, The Scripps Research Institute, 10550 N.
Phylogenetic and genetic analysis of feline immunodeficiency virus gag, pol, and env genes from domestic cats undergoing nucleoside reverse transcriptase inhibitor treatment or treatment-naive cats in Rio de Janeiro, Brazil.
Feline immunodeficiency virus (FIV) is the Lentivirus responsible for an...
Direct Link
3rd September, 2008
Laboratory of Molecular Virology, Department of Genetics, Federal
Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology.
Genetic analyses of feline immunodeficiency viruses provide significant...
Direct Link
30th August, 2008
Laboratory of Genomic Diversity, National Cancer Institute-Frederick,
A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein.
Genetic analyses of feline immunodeficiency viruses provide significant...
Direct Link
30th August, 2008
Retrovirus Center and Virology Section, Department of Experimental
Should accessory proteins be structural components of lentiviral vaccines? Lessons learned from the accessory ORF-A protein of FIV.
The FIV regulatory protein Rev and accessory proteins Vif and ORF-A are...
Direct Link
30th August, 2008
Retrovirus Center and Virology Section, Department of Experimental
Advances in FIV vaccine technology.
Advances in vaccine technology are occurring in the molecular techniques...
Direct Link
30th August, 2008
Department of Veterinary Pathology, College of Veterinary Medicine,
Expression of CD134 and CXCR4 mRNA in term placentas from FIV-infected and control cats.
Feline immunodeficiency virus (FIV) causes a natural infection of domestic...
Direct Link
30th August, 2008
Department of Biological Sciences, Mississippi State University, P.O. Box
[FIV: not a death sentence] 31st July, 2008
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
For the development of feline immunodeficiency virus (FIV) vaccines mostly...
Direct Link
9th July, 2008
Erasmus MC, Institute of Virology, Rotterdam, The Netherlands.
Animal models of retroviral encephalopathies: feline model.
Human immunodeficiency virus infection in children and adults results in a...
Direct Link
27th June, 2008
The Ohio State University, Columbus, Ohio, USA.
Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course.
Immunotherapy of feline immunodeficiency virus (FIV)-infected cats with...
Direct Link
30th May, 2008
Retrovirus Center and Virology Section, Department of Experimental
[FELV infection, the kiss of death] 22nd May, 2008
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional